People have variable recoveries even with traditional methods. That would make a symptom-based comparison (CelGro versus sutures) too open to error. My idea is better.
Ann: CelGro Study Validates High Quality Nerve Repair, page-34
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
0.005(0.79%) |
Mkt cap ! $151.8M | |||
| Open | High | Low | Value | Volume |
| 64.0¢ | 64.0¢ | 63.0¢ | $156.2K | 246.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38222 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 29000 | 2 |
View Market Depth
| Last trade - 15.54pm 19/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |